Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Werner

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
Surgical Endoscopy|October 17, 2018
Laparoscopic right hemicolectomy with CME: standardization using the "critical view" conceptChristoph Werner Strey, Christoph Wullstein, Michel Adamina, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 15, 2009
Intensive dose-dense compared with conventionally scheduled preoperative chemotherapy for high-risk primary breast cancerMichael Untch, Volker Möbus, Walther Kuhn, et al.
Lancet (London, England)|December 6, 2005
Comparison of rapidly cycled tandem high-dose chemotherapy plus peripheral-blood stem-cell support versus dose-dense conventional chemotherapy for adjuvant treatment of high-risk breast cancer: results of a multicentre phase III trialUlrike Anneliese Nitz, Svjetlana Mohrmann, Johannes Fischer, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
Surgical Endoscopy|October 17, 2018
Laparoscopic right hemicolectomy with CME: standardization using the "critical view" conceptChristoph Werner Strey, Christoph Wullstein, Michel Adamina, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 15, 2009
Intensive dose-dense compared with conventionally scheduled preoperative chemotherapy for high-risk primary breast cancerMichael Untch, Volker Möbus, Walther Kuhn, et al.
Lancet (London, England)|December 6, 2005
Comparison of rapidly cycled tandem high-dose chemotherapy plus peripheral-blood stem-cell support versus dose-dense conventional chemotherapy for adjuvant treatment of high-risk breast cancer: results of a multicentre phase III trialUlrike Anneliese Nitz, Svjetlana Mohrmann, Johannes Fischer, et al.
Pageof 5